Saturday, December 11, 2021 4:26:30 AM
Kudos on a hyper-comprehensive and wise answer! I appreciate especially that you go well beyond the simplistic and foolish way-too-often seen blame and hate LP game of '(love LL) hate LP (and LG)'. FWIW, I hardly love either LP or LG, but if NWBO succeeds I know that they will deserve a lion's share of the credit for mostly having made it happen through their blood, sweat, and tears among a few other tireless workers.
Anybody who, like yourself, has served as corporate upper management would likely easily attest to the above paragraph. It's unfortunately all too easy for all and sundry to play the hate game and believe that LP is a wicked dictator who decides everything all on her own and willfully ignores the advice of her many expert advisors, which is a nonsensical caricature of reality. It's like the ignoranti who say that because NWBO explains little about what they are doing, that 'LP, LG, and everybody down the line at NWBO are sitting around doing nothing'. Of course, that is clueless idiocy.
As usual, you write thoroughly and eloquently which FWIW reminded me of the Japanese proverb 'chinmoku wa kin, yuuben wa gin' = silence is gold, eloquence is silver.
Be well, friend!
Anybody who, like yourself, has served as corporate upper management would likely easily attest to the above paragraph. It's unfortunately all too easy for all and sundry to play the hate game and believe that LP is a wicked dictator who decides everything all on her own and willfully ignores the advice of her many expert advisors, which is a nonsensical caricature of reality. It's like the ignoranti who say that because NWBO explains little about what they are doing, that 'LP, LG, and everybody down the line at NWBO are sitting around doing nothing'. Of course, that is clueless idiocy.
As usual, you write thoroughly and eloquently which FWIW reminded me of the Japanese proverb 'chinmoku wa kin, yuuben wa gin' = silence is gold, eloquence is silver.
Be well, friend!
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
